Dr. Lewis holds a Ph.D. in Chemistry from MIT. He has developed new products, started businesses, and holds patents.Upon the death of his father from Alzheimer's, he sought solutions that were answered by his new colleague Dr. Clement Trempe of Harvard Medical School. He has recently completed a book "The End of Alzheimer's, A Differential Diagnosis to a Cure." He is the author of the RealHealth Clincs clinical business plan.

Joe is a seasoned executive addressing the challenges of start-up entities. His experience includes financial and strategy development, and venture capital finance. Joe was cofounder and CEO of Verax Biomedical, a VC backed start-up. He was CFO / VP Finance for two VC-backed companies. He led $51m in private financing, finance lead on two IPOs, multiple private placements, and numerous deals ($311m). Joe is a Certified Public Accountant.

Dr Trempe is a Harvard Medical School professor of Ophthalmology and practicing MD. He is the author of the "Trempe Protocol" that is a mult-step process for the screening, early detection, diagnosis, and treatment of chronic diseases with special emphasis on Alzheimer's. Dr. Trempe uses the eye, which is an extension of the brain, to measure very early and advancing disease progression. He uses blood tests to reveal disease root causes.

Dr. Forbes holds a Doctorate in Education. He has developed methods and processes that enhance a patient’s cognitive abilities and learning and improve performance in focus, attention, organization of thought, speed of thought and executive functions. He is active in health care system innovation and improvement through roles in leadership, education and health care system development.

Dr. Bob Kunz is a seasoned Doctor of Internal Medicine who has worked in the traditional and private pay medical arenas. He went to Indiana University Medical School, graduating in 1983 and elected to Alpha Omega Alpha Honor Medical Society. He is board certified in Internal Medicine, scoring in the 98th percentile for the nation on his boards.